Does eplerenone added to optimal medical therapy reduce morbidity and mortality in patients with acute myocardial infarction complicated by left ventricular dysfunction and heart failure?
Eplerenone added to optimal medical therapy reduces morbidity and mortality in patients with acute MI complicated by LV dysfunction and heart failure.
The addition of eplerenone to optimal medical therapy reduces morbidity and mortality among patients with acute myocardial infarction complicated by left ventricular dysfunction and heart failure.
Pitt et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: